本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

3.60
+0.12053.46%
成交量:6,038
成交额:2.20万
市值:679.88万
市盈率:-0.41
高:3.78
开:3.77
低:3.59
收:3.48
52周最高:26.64
52周最低:3.28
股本:188.83万
流通股本:129.23万
量比:2.23
换手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-8.7319
每股收益(LYR):-8.7319
净资产收益率:-2174.98%
总资产收益率:-247.30%
市净率:-4.36
市盈率(LYR):-0.41

数据加载中...

2026/03/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/25

SEC问询函

Form CORRESP - Correspondence
2025/08/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2024/12/13

SEC问询函

Form CORRESP - Correspondence
2024/12/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC问询函

Form CORRESP - Correspondence
2023/09/01

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC问询函

Form CORRESP - Correspondence
2023/08/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]